The development of optical tweezers dates back to the 1970s when a Bell Laboratory scientist, Arthur Ashkin, first discovered the effect of gradient forces and optical light scattering on a particle. Shortly thereafter, Drs. Ashkin and JM Dziedzic were successfully able to lift a particle in air by creating a single-beam trap. However, it was […]
Company Announcements Frank Witney, president and CEO of Dionex, resigned from Transgenomic’s Board in May. Proteome Sciences licensed Axela’s dotLab System to develop assays to measure its brain damage biomarkers. Axela obtained an option to license the assays for research and diagnostic use. In June, Luminex established an office in Shanghai, China. Luminex named Michael […]
Company Announcements Hach announced that starting in January 2009 its Hach Ultra business was “aligned” with Hach Lange, with all products now sold under the Hach Lange brand. Aqua Diagnostic appointed three new distributors: ManSci for Canada and the US, John Morris Scientific for Australia and New Zealand, and FKV for Italy. ASA Analytics named […]
The Malaysian Organization of Pharmaceutical Industries (MOPI) forecasts the country’s pharmaceutical industry to grow 10% to MYR 9.3 billion ($1.1 billion) this year. Fueling the growth is demand related to the H1NI virus. The generic drug manufacturing industry makes up 35% of the domestic market and is estimated to grow 15% due to growth in […]
Israeli spending on civilian R&D rose 3.6% in constant prices last year to NIS 35.3 billion ($9.2 billion), or 4.9% of GDP. R&D expenditures by business grew 4.5% to make up 81% of the county’s total R&D spending. R&D spending by private nonprofit institutions increased 2.5% to represent 3% of the country’s R&D spending. General […]
Prime Minister Vladimir Putin has announced that Rusnano will invest RUB 40 billion ($1.25 billion) in nanotechnology projects this year, up from the RUM 28 billion in funding announced in May. This amount will represent half of the funding for the 50 projects the state-owned corporation is expected to approve this year. Observers note that […]
Biotechnology: Although financing for biotech companies is improving, it still remains tough. In the first half of 2009, funds raised by biotechnology and specialty pharmaceutical firms increased 41% to $8.3 million, excluding revenue from partnerships. Compared to the first half of 2007, financing was down 55%. Money raised through public offerings and alternative financing rose […]
China’s stimulus plans are accelerating growth in the R&D and technology sectors. Cong Cao of the Levin Graduate Institute of International Relations and Commerce at the State University of New York estimates that CNY 1.4 billion ($205.2 million) of the stimulus plan’s science and technology funding will be used for the country’s Medium- and Long-term […]
The total number of pharmaceutical licensing agreements completed between June 2008 and July 2009 declined 17% year over year to 661, according to EvaluatePharma. Oncology remained the top therapeutic area for licensing agreements, with 132 deals, down 18% from the previous year. Compared to previous periods, more oncology deals focused on earlier stages. The number […]
Primary energy consumption rose 1.4% in 2008 for the slowest growth since 2001, according to the BP Statistical Review of World Energy. Non-OECD nations were responsible for most of the demand, as Asia-Pacific represented 87% of this growth, with China’s energy consumption up 7.2%. Globally, oil production increased 0.4% to 380,000 barrels per day (b/d), […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
